EMMINENCE

This Phase 2 study is a randomized, double-blinded study of three doses of MSDC-0602K or placebo given orally once daily to subjects with biopsy proven NASH with fibrosis and no cirrhosis.  Visits to the clinic will be at baseline, 1, 2, 3, 6, 9, and 12 months, with on 2-week follow-up visit.

Safety will be assessed by monitoring of vital signs, 12-lead electrocardiogram (ECG), physical examinations, safety labs, and adverse events (AEs).

Learn More

Please complete the form below if you are interested in joining a clinical study. Please note that not all who apply are accepted into a trial.

Fields marked with an * are required

Newsletter

Sign up with your name and email address to obtain ongoing updates. Please know that you can ‘opt out’ at any time.

Get In Touch

We’d love to hear from you!

Excel Medical Clinical Trials LLC
7900 Glades Road, Suite 400
Boca Raton, FL 33434